1. What data in particular will be shared?
   Response - All of the individual participant data collected during the trial, after de-identification.
   


2. What additional supporting information will be shared?
   Response -  Study Protocol
   Response -  Statistical Analysis Plan
   Response - Informed Consent Form
   Response - Clinical Study Report
   
   
3. Who will be able to view these files?
   Response - Anyone
   


4. For what types of analyses will this data be available?
   Response - To achieve aims in the approved proposal.
   


5. By what mechanism will data be made available?
   Response - Proposals should be directed to [research@sfeye.org].
   


6. For how long will this data be available start date provided 12-08-2025 and end date provided 14-08-2030?
   Response - Beginning 9 months and ending 36 months following article publication.
   


7. Any URL or additional information regarding plan/policy for sharing IPD? 
   Additional Information - NIL

·         The present study aims to evaluate the use of fibrin glue in rhegmatogenous retinal detachment surgery, potentially transforming current surgical practices and improving visual outcomes in patients.

·         Objectives

·         Primary Objective-

·         Efficacy of the procedure defined as successful anatomical retinal reattachment.

·         Secondary Objectives:

·          Postoperative improvement in BCVA and complications

·         Anticipated Findings: It is expected that fibrin glue will demonstrate early rehabilitation, higher retinal reattachment rates, improved visual outcomes, and fewer complications compared to traditional methods, it will eliminate the problems like use of tamponade ,second  surgery requirement, post-op position on.

·         Implications: Positive results could lead to a shift in clinical practice, offering a more effective and patient-friendly treatment option for rhegmatogenous retinal detachment.